Literature DB >> 29223963

Field evaluation of two point-of-care tests for syphilis among men who have sex with men, Verona, Italy.

Antonella Zorzi1, Maddalena Cordioli2, Lorenzo Gios3, Paola Del Bravo4, Igor Toskin5, Rosanna W Peeling6, Karel Blondeel5,7, Giuseppe Cornaglia1, James Kiarie5, Ronald Ballard5, Massimo Mirandola2,3.   

Abstract

OBJECTIVES: The incidence of HIV and syphilis among men who have sex with men (MSM) in Europe has recently increased. Rapid point-of-care tests (POCTs) for syphilis can improve access to screening. The purpose of this study was to evaluate the performance of two syphilis POCTs compared with laboratory tests among MSM.
METHODS: The study was undertaken in Verona, Italy. Asymptomatic MSM, potentially exposed to syphilis, were enrolled prospectively. The POCTs evaluated were SD Bioline Syphilis 3.0 and Chembio DPP Syphilis Screen & Confirm Assay on both serum and fingerprick blood. The results of the POCTs were read by the naked eye by two independent readers and their concordance assessed.
RESULTS: A total of 289 MSM were enrolled in the study. Based on laboratory tests, 35 MSM (12.1%) were TPPA-positive alone and 16 (5.5%) were both Treponema pallidum particle agglutination test (TPPA) and rapid plasma reagin (RPR)-positive. The specificities of both POCTs were above 99% on both serum and fingerstick blood specimens, while sensitivities varied considerably. The sensitivity of the SD Bioline test was lower on fingerprick blood (51.4% and 54.3%, readers 1 and 2, respectively) compared with that on serum (80.0% and 82.9%). In contrast, the Chembio test exhibited similar sensitivity values for serum and fingerprick samples (57.7% and 64.0% on serum vs 65.4% and 69.2% on fingerprick for the treponemal component; 63.6% on both samples by both readers for the non-treponemal component). The positive predictive value ranged between 100% and 93.9% for the treponemal component of both syphilis POCTs, but was lower (76.3%-100%)%) for the non-treponemal component of the Chembio POCT. The negative predictive value surpassed 90% for both tests on both samples. The agreement between readers was very high (>99%).
CONCLUSION: The diagnostic performance of the syphilis POCTs was lower than expected; however, considering the prevalence of syphilis among MSM, POCTs should be recommended to improve syphilis detection among MSM. © World Health Organization [2017]. Licensee BMJ Publishing Group Limited. This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (CC BY 4.0), which permits use, distribution, and reproduction for non-commercial purposes in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL.

Entities:  

Keywords:  evaluation study; men who have sex with men; point-of-care testing; screening; syphilis

Mesh:

Substances:

Year:  2017        PMID: 29223963     DOI: 10.1136/sextrans-2016-053065

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  13 in total

1.  Laboratory Evaluation of a Commercially Available Rapid Syphilis Test.

Authors:  Lara E Pereira; Joshua McCormick; Tandin Dorji; Joseph Kang; Yongcheng Sun; Mayur Shukla; Andre Hopkins; John Deutsch; Ellen N Kersh; Kyle Bernstein; Yetunde F Fakile
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

2.  Laboratory evaluation of two point-of-care test kits for the identification of infectious syphilis.

Authors:  Raymond Sw Tsang; Michelle Shuel; Kristy Hayden; Paul Van Caeseele; Derek Stein
Journal:  Can Commun Dis Rep       Date:  2022-02-24

3.  Point-of-Care Diagnostics for Diagnosis of Active Syphilis Infection: Needs, Challenges and the Way Forward.

Authors:  Minh D Pham; Jason J Ong; David A Anderson; Heidi E Drummer; Mark Stoové
Journal:  Int J Environ Res Public Health       Date:  2022-07-04       Impact factor: 4.614

4.  Laboratory Evaluation of the DPP Syphilis Screen & Confirm Assay.

Authors:  Silver K Vargas; Jazmin Qquellon; Francesca Vasquez; Kelika A Konda; Gino Calvo; Michael Reyes-Diaz; Carlos Caceres; Jeffrey D Klausner
Journal:  Microbiol Spectr       Date:  2022-05-31

5.  Socio-Demographic Characteristics and Sexual Behavioral Factors of Patients with Sexually Transmitted Infections Attending a Hospital in Southern Italy.

Authors:  Teresa Fasciana; Giuseppina Capra; Paola Di Carlo; Cinzia Calà; Marco Vella; Giuseppe Pistone; Claudia Colomba; Anna Giammanco
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

6.  The resurgence of syphilis in high-income countries in the 2000s: a focus on Europe.

Authors:  G Spiteri; M Unemo; O Mårdh; A J Amato-Gauci
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

7.  Using a dual antibody point-of-care test with visual and digital reads to diagnose syphilis among people living with HIV in Botswana.

Authors:  Irfaan Maan; David S Lawrence; Nametso Tlhako; Kehumile Ramontshonyana; Aamirah Mussa; Adriane Wynn; Michael Marks; Doreen Ramogola-Masire; Chelsea Morroni
Journal:  Int J STD AIDS       Date:  2021-02-11       Impact factor: 1.359

8.  Field evaluation of SD BIOLINE HIV/Syphilis Duo assay among pregnant women attending routine antenatal care in Juba, South Sudan.

Authors:  Dennis K Lodiongo; Bior K Bior; Gregory W Dumo; Joel S Katoro; Juma J H Mogga; Michael L Lokore; Abe G Abias; Jane Y Carter; Lul L Deng
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

9.  Consider Syphilis in Case of Lymphopenia in HIV-Infected Men Who Have Sex with Men (MSM): A Single-center, Retrospective Study.

Authors:  Georgios Sogkas; Diana Ernst; Faranaz Atschekzei; Alexandra Jablonka; Reinhold E Schmidt; Georg M N Behrens; Matthias Stoll
Journal:  Infect Dis Ther       Date:  2018-10-30

10.  Standardised protocol for a prospective cross-sectional multicentre clinic-based evaluation of two dual point-of-care tests for the screening of HIV and syphilis in men who have sex with men, sex workers and pregnant women.

Authors: 
Journal:  BMJ Open       Date:  2020-11-26       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.